Lotronex (alosetron) off the market

After months of wrangling with the FDA, Glaxo is now taking Lotronex (alosetron) off the market.

Lotronex was just introduced last March...for women with diarrhea-predominant irritable bowel syndrome.

But since then, there have been an increasing number of reports of ischemic colitis and complications of severe constipation in Lotronex patients...including several deaths.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote